๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study

โœ Scribed by Palmeri, S; Gebbia, V; Russo, A; Armata, MG; Gebbia, N; Rausa, L

Book ID
109836343
Publisher
Nature Publishing Group
Year
1990
Tongue
English
Weight
741 KB
Volume
61
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II study of CHIP chemotherapy in a
Phase II study of CHIP chemotherapy in advanced adenocarcinomas of the upper gastrointestinal tract
โœ Alec S. Goldenberg; David Kelsen; James Dougherty; Gordon Magill ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer US ๐ŸŒ English โš– 412 KB

Iproplatin (CHIP) is a second generation cisplatin analogue which has completed its Phase I trials. We studied the efficacy and toxicity of CHIP in 36 previously untreated patients with advanced upper gastrointestinal tract adenocarcinomas (GE junction, cardia, antrum and body of the stomach). The s

A phase II trial of oral tegafur and ura
A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer
โœ Yukito Ichinose; Nobuko Takanashi; Tokujiro Yano; Hiroshi Asoh; Hideki Yokoyama; ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 391 KB ๐Ÿ‘ 2 views

## Background: The combination of uracil and tegafur in a 4:1 molar concentration (uft) has a greater antitumor activity than 5-fluorouracil (5-fu) and tegafur. because the combination of 5-fu and cisplatin has been proven to have a synergistic antitumor effect in many experimental and clinical stu